跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 82,557 条关于
“anti-PD-1 oncology biosimilar”
全部
82,557
临床试验
46,494
药物
11,936
机构
1,692
资讯
22,435
去年
Teva and mAbxience Expand Partnership with New Anti-PD-1 Oncology Biosimilar
去年
Teva and mAbxience Expand Partnership with New PD-1 Biosimilar Candidate
去年
Golidocitinib Plus PD-1 Antibodies Shows Promise in NSCLC Patients After Anti-PD-1 Therapy Failure
2年前
Camrelizumab Shows Promise in Initially Unresectable NSCLC
13年前
European Market Access Hurdles Loom for PD-1/PD-L1 Immunotherapies in Oncology
4年前
Combination Immunotherapies Show Promise in Pancreatic Cancer Treatment
11个月前
Anti-PD-1 Immunotherapy Shows Promise for Drug-Free HIV Control in Phase 1 Trial
去年
LaNova Medicines Initiates Phase 1 Trial of LM-299, Anti-PD-1/VEGF Bispecific Antibody, for Advanced Solid Tumors
3个月前
MediciNova Secures U.S. Patent Allowance for Ibudilast–Anti-PD-1 Combination in Glioblastoma
去年
Ipilimumab and Nivolumab Show Promise in Treating Rare Desmoid Tumors
第 1 页，共 2244 页
上一页
下一页
